Antibacterial Prophylaxis after Chemotherapy for Solid Tumors and Lymphomas
Open Access
- 8 September 2005
- journal article
- clinical trial
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 353 (10), 988-998
- https://doi.org/10.1056/nejmoa050078
Abstract
The role of prophylactic antibacterial agents after chemotherapy remains controversial.Keywords
This publication has 16 references indexed in Scilit:
- Antibacterial resistance worldwide: causes, challenges and responsesNature Medicine, 2004
- Impact of neutropenia on delivering planned adjuvant chemotherapy: UK audit of primary breast cancer patientsBritish Journal of Cancer, 2003
- Economic evaluation of antibiotic prophylaxis in small-cell lung cancer patients receiving chemotherapy: an EORTC double-blind placebo-controlled phase III study (08923)Annals of Oncology, 2003
- 2000 Update of Recommendations for the Use of Hematopoietic Colony-Stimulating Factors: Evidence-Based, Clinical Practice GuidelinesJournal of Clinical Oncology, 2000
- Efficacy of quinolone prophylaxis in neutropenic cancer patients: a meta-analysis.Journal of Clinical Oncology, 1998
- 1997 Guidelines for the Use of Antimicrobial Agents in Neutropenic Patients with Unexplained FeverClinical Infectious Diseases, 1997
- Prophylaxis with Fluoroquinolones for Bacterial Infections in Neutropenic Patients: A Meta-AnalysisClinical Infectious Diseases, 1996
- Prevention of Infections in the Neutropenic PatientClinical Infectious Diseases, 1993
- In vitro and in vivo antibacterial activities of levofloxacin (l-ofloxacin), an optically active ofloxacinAntimicrobial Agents and Chemotherapy, 1992
- Indications for Systemic Antibiotic Prophylaxis in Neutropenic PatientsBMJ, 1974